• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

威斯康星州先天性肾上腺皮质增生症新生儿筛查算法

Wisconsin's Screening Algorithm for the Identification of Newborns with Congenital Adrenal Hyperplasia.

作者信息

Bialk Eric R, Lasarev Michael R, Held Patrice K

机构信息

Wisconsin State Laboratory of Hygiene, University of Wisconsin School of Medicine and Public Health, Madison, WI 53706, USA.

Department of Biostatistics and Medical Informatics, University of Wisconsin School of Medicine and Public Health, Madison, WI 53726, USA.

出版信息

Int J Neonatal Screen. 2019 Sep 6;5(3):33. doi: 10.3390/ijns5030033. eCollection 2019 Sep.

DOI:10.3390/ijns5030033
PMID:33072992
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7510207/
Abstract

Newborn screening for congenital adrenal hyperplasia (CAH) has one of the highest false positive rates of any of the diseases on the Wisconsin panel. This is largely due to the first-tier immune assay cross-reactivity and physiological changes in the concentration of 17-hydroxyprogesterone during the first few days of life. To improve screening for CAH, Wisconsin developed a second-tier assay to quantify four different steroids (17-hydroxyprogesterone, 21-deoxycortisol, androstenedione, and cortisol) by liquid chromatography-tandem mass spectrometry (LC-MSMS) in dried blood spots. From validation studies which included the testing of confirmed CAH patients, Wisconsin established its own reporting algorithm that incorporates steroid concentrations as well as two different ratios-the birth weight and the collection time-to identify babies at risk for CAH. Using the newly developed method and algorithm, the false positive rate for the CAH screening was reduced by 95%. Patients with both classical forms of CAH, salt-wasting and simple virilizing, were identified. This study replicates and expands upon previous work to develop a second-tier LC-MSMS steroid profiling screening assay for CAH. The validation and prospective study results provide evidence for an extensive reporting algorithm that incorporates multiple steroids, birth weight, and collection times.

摘要

新生儿先天性肾上腺皮质增生症(CAH)筛查的假阳性率在威斯康星州检测的所有疾病中位居前列。这主要归因于一级免疫测定的交叉反应以及出生后几天内17-羟孕酮浓度的生理变化。为改进CAH筛查,威斯康星州开发了一种二级检测方法,通过液相色谱-串联质谱法(LC-MSMS)对干血斑中的四种不同类固醇(17-羟孕酮、21-脱氧皮质醇、雄烯二酮和皮质醇)进行定量。通过包括对确诊CAH患者进行检测的验证研究,威斯康星州建立了自己的报告算法,该算法纳入了类固醇浓度以及两个不同的比率——出生体重和采集时间,以识别有CAH风险的婴儿。使用新开发的方法和算法,CAH筛查的假阳性率降低了95%。同时识别出了患有经典型CAH(失盐型和单纯男性化型)的患者。本研究重复并扩展了先前的工作,开发了一种用于CAH的二级LC-MSMS类固醇谱筛查检测方法。验证和前瞻性研究结果为一种纳入多种类固醇、出生体重和采集时间的广泛报告算法提供了证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96d0/7510207/23bd9ab5f86d/IJNS-05-00033-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96d0/7510207/3908466214b4/IJNS-05-00033-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96d0/7510207/909cdce3ef0b/IJNS-05-00033-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96d0/7510207/23bd9ab5f86d/IJNS-05-00033-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96d0/7510207/3908466214b4/IJNS-05-00033-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96d0/7510207/909cdce3ef0b/IJNS-05-00033-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/96d0/7510207/23bd9ab5f86d/IJNS-05-00033-g003.jpg

相似文献

1
Wisconsin's Screening Algorithm for the Identification of Newborns with Congenital Adrenal Hyperplasia.威斯康星州先天性肾上腺皮质增生症新生儿筛查算法
Int J Neonatal Screen. 2019 Sep 6;5(3):33. doi: 10.3390/ijns5030033. eCollection 2019 Sep.
2
Steroid profile in dried blood spots by liquid chromatography tandem mass spectrometry: Application to newborn screening for congenital adrenal hyperplasia in China.液相色谱串联质谱法测定干血斑中的类固醇谱:在中国先天性肾上腺皮质增生症新生儿筛查中的应用。
Steroids. 2022 Sep;185:109056. doi: 10.1016/j.steroids.2022.109056. Epub 2022 May 31.
3
Neonatal Screening for Congenital Adrenal Hyperplasia in Turkey: A Pilot Study with 38,935 Infants.土耳其先天性肾上腺皮质增生症的新生儿筛查:一项针对38935名婴儿的试点研究。
J Clin Res Pediatr Endocrinol. 2019 Feb 20;11(1):13-23. doi: 10.4274/jcrpe.galenos.2018.2018.0117. Epub 2018 Aug 14.
4
Steroid profiling for congenital adrenal hyperplasia by tandem mass spectrometry as a second-tier test reduces follow-up burdens in a tertiary care hospital: a retrospective and prospective evaluation.串联质谱法进行先天性肾上腺皮质增生症的类固醇谱分析作为二线检测可减少三级医院的随访负担:回顾性和前瞻性评估。
J Perinat Med. 2014 Jan;42(1):121-7. doi: 10.1515/jpm-2013-0154.
5
Implementing steroid profiling by liquid chromatography-tandem mass spectrometry improves newborn screening for congenital adrenal hyperplasia in New Zealand.液相色谱-串联质谱法实施类固醇分析可提高新西兰先天性肾上腺皮质增生症的新生儿筛查效果。
Clin Endocrinol (Oxf). 2021 Jun;94(6):904-912. doi: 10.1111/cen.14422. Epub 2021 Jan 31.
6
Neonatal Screening for Congenital Adrenal Hyperplasia in Turkey: Outcomes of Extended Pilot Study in 241,083 Infants.土耳其新生儿先天性肾上腺皮质增生症的筛查:241083 例婴儿扩展试点研究的结果。
J Clin Res Pediatr Endocrinol. 2020 Sep 2;12(3):287-294. doi: 10.4274/jcrpe.galenos.2020.2019.0182. Epub 2020 Mar 11.
7
Improved specificity of newborn screening for congenital adrenal hyperplasia by second-tier steroid profiling using tandem mass spectrometry.通过串联质谱法进行二线类固醇分析提高先天性肾上腺皮质增生症新生儿筛查的特异性
Clin Chem. 2004 Mar;50(3):621-5. doi: 10.1373/clinchem.2003.027193. Epub 2003 Dec 4.
8
Use of steroid profiling by UPLC-MS/MS as a second tier test in newborn screening for congenital adrenal hyperplasia: the Utah experience.采用超高效液相色谱-串联质谱法进行类固醇谱分析作为先天性肾上腺皮质增生症新生儿筛查的二线检测方法:犹他州的经验。
Pediatr Res. 2009 Aug;66(2):230-5. doi: 10.1203/PDR.0b013e3181aa3777.
9
Concurrent Confirmation and Differential Diagnosis of Congenital Adrenal Hyperplasia from Dried Blood Spots: Application of a Second-Tier LC-MS/MS Assay in a Cross-Border Cooperation for Newborn Screening.通过干血斑对先天性肾上腺皮质增生症进行同步确认和鉴别诊断:二级液相色谱-串联质谱分析法在新生儿筛查跨境合作中的应用
Horm Res Paediatr. 2015;84(5):311-8. doi: 10.1159/000439380. Epub 2015 Sep 24.
10
Newborn screening for congenital adrenal hyperplasia: additional steroid profile using liquid chromatography-tandem mass spectrometry.先天性肾上腺皮质增生症的新生儿筛查:使用液相色谱-串联质谱法检测额外的类固醇谱。
J Clin Endocrinol Metab. 2007 Jul;92(7):2581-9. doi: 10.1210/jc.2006-2890. Epub 2007 Apr 24.

引用本文的文献

1
Newborn screening for congenital adrenal hyperplasia: Utility of liquid chromatography with tandem mass spectrometry as a secondary test.先天性肾上腺皮质增生症的新生儿筛查:液相色谱串联质谱作为二级检测方法的效用
Clin Pediatr Endocrinol. 2025 Jan;34(1):13-18. doi: 10.1297/cpe.2024-0069. Epub 2024 Nov 25.
2
Green method for 17-hydroxyprogesterone extraction and determination using PDMS stir bar sorptive extraction coupled with HPLC: optimization by response surface methodology.采用 PDMS 搅拌棒吸附萃取与 HPLC 联用的 17-羟孕酮提取和测定的绿色方法:响应面法优化。
Sci Rep. 2024 Jul 13;14(1):16192. doi: 10.1038/s41598-024-66355-9.
3

本文引用的文献

1
Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline.先天性肾上腺皮质增生症由类固醇 21-羟化酶缺陷引起:内分泌学会临床实践指南。
J Clin Endocrinol Metab. 2018 Nov 1;103(11):4043-4088. doi: 10.1210/jc.2018-01865.
2
Neonatal Screening for Congenital Adrenal Hyperplasia in Turkey: A Pilot Study with 38,935 Infants.土耳其先天性肾上腺皮质增生症的新生儿筛查:一项针对38935名婴儿的试点研究。
J Clin Res Pediatr Endocrinol. 2019 Feb 20;11(1):13-23. doi: 10.4274/jcrpe.galenos.2018.2018.0117. Epub 2018 Aug 14.
3
Clinical and molecular profile of newborns with confirmed or suspicious congenital adrenal hyperplasia detected after a public screening program implementation.
Congenital Adrenal Hyperplasia - A Comprehensive Review of Genetic Studies on 21-Hydroxylase Deficiency from India.
先天性肾上腺皮质增生症——印度21-羟化酶缺乏症基因研究的综合综述
Indian J Endocrinol Metab. 2024 Mar-Apr;28(2):117-128. doi: 10.4103/ijem.ijem_303_23. Epub 2024 Apr 29.
4
Second-tier strategies in newborn screening - potential and limitations.新生儿筛查中的二线策略——潜力与局限
Med Genet. 2022 May 7;34(1):21-28. doi: 10.1515/medgen-2022-2117. eCollection 2022 Apr.
5
Can Incorporating Molecular Testing Improve the Accuracy of Newborn Screening for Congenital Adrenal Hyperplasia?纳入分子检测能否提高先天性肾上腺皮质增生症新生儿筛查的准确性?
J Clin Endocrinol Metab. 2025 Mar 17;110(4):e1194-e1203. doi: 10.1210/clinem/dgae297.
6
The impact of neonatal 17-hydroxyprogesterone cutoff determination in a public newborn screening program for congenital adrenal hyperplasia in Southern Brazil: 3 years' experience.巴西南部先天性肾上腺皮质增生症公共新生儿筛查项目中新生儿17-羟孕酮临界值测定的影响:3年经验
Endocr Connect. 2023 Oct 30;12(12). doi: 10.1530/EC-23-0162. Print 2023 Dec 1.
7
The use of liquid chromatography-tandem mass spectrometry in newborn screening for congenital adrenal hyperplasia: improvements and future perspectives.液相色谱-串联质谱在先天性肾上腺皮质增生症新生儿筛查中的应用:改进与未来展望。
Front Endocrinol (Lausanne). 2023 Oct 2;14:1226284. doi: 10.3389/fendo.2023.1226284. eCollection 2023.
8
Multiple 17-OHP Cutoff Co-Variates Fail to Improve 21-Hydroxylase Deficiency Screening Accuracy.多个17-羟孕酮临界值协变量未能提高21-羟化酶缺乏症的筛查准确性。
Int J Neonatal Screen. 2022 Oct 25;8(4):57. doi: 10.3390/ijns8040057.
9
Challenges in Assessing the Cost-Effectiveness of Newborn Screening: The Example of Congenital Adrenal Hyperplasia.评估新生儿筛查成本效益的挑战:以先天性肾上腺皮质增生症为例。
Int J Neonatal Screen. 2020 Oct 25;6(4):82. doi: 10.3390/ijns6040082.
10
CAH Newborn Screening in India: Challenges and Opportunities.印度的先天性肾上腺皮质增生症新生儿筛查:挑战与机遇
Int J Neonatal Screen. 2020 Aug 27;6(3):70. doi: 10.3390/ijns6030070.
实施公共筛查项目后确诊或疑似先天性肾上腺皮质增生症新生儿的临床和分子特征。
J Pediatr (Rio J). 2019 May-Jun;95(3):282-290. doi: 10.1016/j.jped.2018.03.003. Epub 2018 Apr 30.
4
A Liquid Chromatography/Tandem Mass Spectometry Profile of 16 Serum Steroids, Including 21-Deoxycortisol and 21-Deoxycorticosterone, for Management of Congenital Adrenal Hyperplasia.用于先天性肾上腺皮质增生症管理的16种血清类固醇(包括21-脱氧皮质醇和21-脱氧皮质酮)的液相色谱/串联质谱分析图谱
J Endocr Soc. 2017 Feb 10;1(3):186-201. doi: 10.1210/js.2016-1048. eCollection 2017 Mar 1.
5
Congenital adrenal hyperplasia.先天性肾上腺皮质增生症。
Lancet. 2017 Nov 11;390(10108):2194-2210. doi: 10.1016/S0140-6736(17)31431-9. Epub 2017 May 30.
6
Determination of a steroid profile in heel prick blood using LC-MS/MS.使用液相色谱-串联质谱法测定足跟采血中的类固醇谱。
Bioanalysis. 2016;8(5):375-84. doi: 10.4155/bio.16.6. Epub 2016 Feb 19.
7
Damaged goods?: an empirical cohort study of blood specimens collected 12 to 23 hours after birth in newborn screening in California.受损的商品?:加利福尼亚州新生儿筛查中在出生后 12 至 23 小时采集的血液标本的一项实证队列研究。
Genet Med. 2016 Mar;18(3):259-64. doi: 10.1038/gim.2015.154. Epub 2015 Dec 10.
8
Biochemical and genetic diagnosis of 21-hydroxylase deficiency.21-羟化酶缺乏症的生化与遗传学诊断
Endocrine. 2015 Nov;50(2):306-14. doi: 10.1007/s12020-015-0731-6. Epub 2015 Sep 4.
9
Congenital adrenal hyperplasia cases identified by newborn screening in one- and two-screen states.在单筛和双筛州通过新生儿筛查确诊的先天性肾上腺皮质增生症病例。
Mol Genet Metab. 2015 Nov;116(3):133-8. doi: 10.1016/j.ymgme.2015.08.004. Epub 2015 Aug 12.
10
Comparison of newborn screening protocols for congenital adrenal hyperplasia in preterm infants.早产儿先天性肾上腺皮质增生症新生儿筛查方案的比较。
J Pediatr. 2014 May;164(5):1136-40. doi: 10.1016/j.jpeds.2014.01.038. Epub 2014 Feb 28.